NovaBridge Biosciences - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US44975P1030
1,44 € ↓ -0,10 (-6,49%)
2026-06-02
DEL PRIS
SecurityDE:0VY / NovaBridge Biosciences - Depositary Receipt (Common Stock)
InstitutionUBS Group AG
Latest Disclosed Ownership63,541 shares
Latest Disclosed Value $ 156,311
UBS Group AG reports 65.04% decrease in ownership of 0VY / NovaBridge Biosciences - Depositary Receipt (Common Stock)

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 63,541 shares of NovaBridge Biosciences - Depositary Receipt (Common Stock) (DE:0VY) valued at $122,634 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 181,776 shares of NovaBridge Biosciences - Depositary Receipt (Common Stock). This represents a change in shares of -65.04% during the quarter. The current value of the position is $91,499 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F NOVABRIDGE BIOSCIENCES SPONSORED ADS 44975P103 63,541 -118,235 -65.04 156 -78.42 0.0000
2026-01-29 2025-12-31 13F NOVABRIDGE BIOSCIENCES SPONSORED ADS 44975P103 181,776 -113,302 -38.40 723 -35.16 0.0001
2025-11-13 2025-09-30 13F I MAB SPONSORED ADS 44975P103 295,078 110,233 59.64 1,115 149.44 0.0002
2025-08-14 2025-06-30 13F I MAB SPONSORED ADS 44975P103 184,845 -133,701 -41.97 447 70.61 0.0001
2025-05-13 2025-03-31 13F I MAB SPONSORED ADS 44975P103 318,546 215,492 209.11 262 201.15 0.0000
2025-02-14 2024-12-31 13F I MAB SPONSORED ADS 44975P103 103,054 103,054 88 0.0000
2024-11-14 2024-09-30 13F I MAB SPONSORED ADS 44975P103 0 -12,514 -100.00 0 -100.00
2024-08-14 2024-06-30 13F I MAB SPONSORED ADS 44975P103 12,514 11,183 840.20 21 900.00 0.0000
2024-05-13 2024-03-31 13F I MAB SPONSORED ADS 44975P103 1,331 -13,948 -91.29 2 -93.10 0.0000
2024-02-09 2023-12-31 13F I MAB SPONSORED ADS 44975P103 15,279 -543,274 -97.26 29 -96.07 0.0000
2023-11-09 2023-09-30 13F I MAB SPONSORED ADS 44975P103 558,553 20,894 3.89 737 -54.14 0.0003
2023-08-11 2023-06-30 13F I MAB SPONSORED ADS 44975P103 537,659 6,465 1.22 1,608 -12.52 0.0005
2023-05-12 2023-03-31 13F I MAB SPONSORED ADS 44975P103 531,194 -12,278 -2.26 1,838 -19.11 0.0007
2023-02-08 2022-12-31 13F I MAB SPONSORED ADS 44975P103 543,472 432,657 390.43 2,272 411.49 0.0008
2022-11-10 2022-09-30 13F I MAB SPONSORED ADS 44975P103 110,815 -108,344 -49.44 444 -82.08 0.0002
2022-08-10 2022-06-30 13F I MAB SPONSORED ADS 44975P103 219,159 116,918 114.36 2,477 49.13 0.0010
2022-05-16 2022-03-31 13F I MAB SPONSORED ADS 44975P103 102,241 31,577 44.69 1,661 -50.40 0.0006
2022-02-14 2021-12-31 13F I MAB SPONSORED ADS 44975P103 70,664 -23,638 -25.07 3,349 -51.01 0.0010
2021-11-15 2021-09-30 13F I MAB SPONSORED ADS 44975P103 94,302 -75,692 -44.53 6,836 -52.10 0.0022
2021-08-13 2021-06-30 13F I MAB SPONSORED ADS 44975P103 169,994 169,334 25,656.67 14,271 44,496.88 0.0046
2021-05-12 2021-03-31 13F I MAB SPONSORED ADS 44975P103 660 64 10.74 32 14.29 0.0000
2021-02-11 2020-12-31 13F I MAB SPONSORED ADS 44975P103 596 -17,628 -96.73 28 -96.73 0.0000
2020-11-12 2020-09-30 13F I MAB SPONSORED ADS 44975P103 18,224 18,224 857 0.0003
2020-07-31 2020-06-30 13F I MAB SPONSORED ADS 44975P103 0 -1,985 -100.00 0 -100.00
2020-05-01 2020-03-31 13F I MAB SPONSORED ADS 44975P103 1,985 1,985 26 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.